Reports first-half FY23:
Production of 309,255 dry metric tonnes of spodumene, up 83%
Shipments of 286,876 dmt of spodumene, up 68%
Sales revenue of $2.18bn, up 647%: In-line with $2.20bn expected
Statutory net profit of $1.24bn, up 989%
Cash balance of $2.23bn compared to $591.7m a year ago
Inaugural dividend of 11 cents per share
FY23 guidance:
Spodumene production upgraded to 600-620,000 dry metric tonnes, up from 540-580,000 dmt
Unit operating cost of $580-610 dmt, down from previous guidance of $635-700 dmt
Reports H1:
NPAT of US$222.5m vs. expectations of US$249.7m
Revenue of US$557.9m vs. expectations of US$573.7m
EBITDAIX of US$401.5m vs. US$97.8m in 1HFY22
Discontinued operations cost of -US$3.2m in the period
Final continuous operations profit of US$219.23m
Reports H1:
H1 NPAT (cont ops) $20m, swinging from last year’s $20.2m loss
Operating Revenue $43.7m, up 136% from last year’s $18.5m
EBITDA (cont ops, ex-items) $0.3m, up from last year’s ($16.4m)
From management:
Group is well capitalised to fund its recovery and future investments, which include over $50m of new and upgraded rides and attractions
Reports H1:
Loss of -$2m in EBITDA vs. EBITDA of $71.1m in 1HFY22
NPAT loss of -$7m vs. profit of $45.1m in 1HFY22
Orders currently stand at $6.9m
Dividend of 4c (100% franked)
Outlook and guidance:
EBIT taret of $58m reaffirmed despite loss
"Continues to see potential upside from major shipbuilding opportunities"
Strong pipeline of orders in short-to-medium-term
"Well on track to achieve strategic growth target of A$500m annual support revenue by FY27"
Reports H1:
Underlying NPAT A$18.2, up 8% on last year’s $16.8m
Revenue $62.4m, up 18% on last year’s $52.8m
EBITDA A$30.2M, up 7% on last year’s $28.2m
TTV $417m
Interim DPS A$0.239 (+4.5% pcp), fully franked; record 3-Mar; payable 17-Mar
Div payout ratio 84.2% – at top end targeted 65-85% range.
FY23 Outlook:
Reaffirms FY23 Outlook
Underlying operating cost growth excluding Lottery Retailing marketing costs is anticipated to moderate with Jumbo targeting an increase of 16-18%
Underlying EBITDA margin is anticipated to be at the upper end of the original range of 48-50%a
Reports H1:
Underlying NPAT of $334.5m vs. expectations of $321.9m
Revenue of $2.93b mostly in line with expectations of $2.91bn
Underlying profit of $548m vs. expectations of $511.4m
Interim 12c dividend payable 13th of April
CFO Nessa O'Sullivan retiring
Outlook and guidance:
Sales revenue +12-14% vs. FY22
Underlying profit of +15-18% vs. FY22
Free cash flow after dividends to improve over FY22 "but remain a net outflow"
Dividend payout ratio of 45-60%
Reports H1:
H1 underlying NPAT $388.6m against expectations of $465m
Revenue $2.35bn against expectations of $2.41bn
Adjusted EBITDA $939m (up 503% from last year) against expectations of $990m
Interim dividend $1.20 (fully franked); record 10-Mar, payment 30-Mar
MinRes achieved record lithium earnings from the conversion of Mt Marion and Wodinga spodumene concentrate into battery chemicals.
Reports first-half FY23:
Revenue of $592.2m, up 0.2%
Operating EBITDA of $128.3m, up 7.8%
Operating NPATA (ex-Pexa) of $38.2m, up 4.9%
Revenue and NPATA both missed analyst expectations
Statutory NPAT of -$410.1m
Dividend of 4.5 cents per share, up 50%
Guidance:
Reaffirmed FY23 revenue guidance of $1.19-1.22bn
Expects full-year result to track towards lower end of guidance
Get the latest news and insights direct to your inbox